Friday, July 10, 2026
🇺🇸 FDA

pharma · Prurigo Nodularis · Vitiligo

Incyte

Incyte trial registry — 54 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
1801 Augustine Cut-Off, Wilmington, Delaware 19803, US HQ
3,381 Employees
NMPA registrant Type
Company details
Status
Public
HQ
1801 Augustine Cut-Off, Wilmington, Delaware 19803, US
Employees
3,381
Programs
53
Drugs
61
Patents
0
Official website ↗ All projects Drug pipeline News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Incyte clinical trials

Registry index of 54 ClinicalTrials.gov studies linked to Incyte programs — each row shows trial ID, program name, phase, status, and indication.

Incyte trial registry — 54 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Incyte.

  1. INCA 33989-101 — Phase 1

    Clinical update

  2. INCB 81776-101 — Phase 1

    Clinical update

  3. MOR208C310 — Phase 3

    Clinical update

  4. MOR208C115 — Phase 2

    Clinical update

  5. MK-3475-679 — Phase 3

    Clinical update

  6. INCMOR0208-301 — Phase 3

    Clinical update

  7. INCMOR 0208-305 — Phase 3

    Clinical update

  8. INCMGA0012-204 — Phase 2

    Clinical update

Trial registry

54 studies
  28. 2024-512015-47-00

    MK-3475-669

    Phase 3 active small_molecule

    Histologically or cytologically-confirmed Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma that is considered incurable by local therapies

    CTIS ↗

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.